786 related articles for article (PubMed ID: 8667429)
21. Risk of endometrial, ovarian, vulvar, and vaginal cancers after a positive cervical cytology followed by negative histology.
Viikki M; Pukkala E; Hakama M
Obstet Gynecol; 1998 Aug; 92(2):269-73. PubMed ID: 9699765
[TBL] [Abstract][Full Text] [Related]
22. The contribution of rapid intraoperative cytology in the evaluation of endometrial cancer spread.
Anastasiadis P; Koutlaki N; Liberis V; Tsikouras P; Dimitraki M; Liberis A; Galazios G
Ann Acad Med Singap; 2011 Feb; 40(2):80-3. PubMed ID: 21468461
[TBL] [Abstract][Full Text] [Related]
23. Peritoneal washing cytology. Uses and diagnostic criteria in gynecologic neoplasms.
Ziselman EM; Harkavy SE; Hogan M; West W; Atkinson B
Acta Cytol; 1984; 28(2):105-10. PubMed ID: 6583966
[TBL] [Abstract][Full Text] [Related]
24. [Clinical analysis of 23 cases with simultaneous double primary gynecological malignant tumors].
He Y; Wang Y; Ji C; Liu Y; Wu YM
Zhonghua Fu Chan Ke Za Zhi; 2022 May; 57(5):352-360. PubMed ID: 35658326
[No Abstract] [Full Text] [Related]
25. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
[TBL] [Abstract][Full Text] [Related]
26. The prognostic value of peritoneal cytology in ovarian cancer.
Simojoki M; Santala M; Vuopala S; Kauppila A
Eur J Gynaecol Oncol; 1999; 20(5-6):357-60. PubMed ID: 10609494
[TBL] [Abstract][Full Text] [Related]
27. Detection of disseminated tumor cells in patients with gynecological cancers.
Fehm T; Becker S; Bachmann C; Beck V; Gebauer G; Banys M; Wallwiener D; Solomayer EF
Gynecol Oncol; 2006 Dec; 103(3):942-7. PubMed ID: 16889820
[TBL] [Abstract][Full Text] [Related]
28. The prognostic role of peritoneal cytology in stage IA endometrial endometrioid carcinomas.
Wang L; Li L; Wu M; Lang J
Curr Probl Cancer; 2020 Apr; 44(2):100514. PubMed ID: 31753315
[TBL] [Abstract][Full Text] [Related]
29. Peritoneal cytology in patients with uterine cervical carcinoma.
Ito K; Noda K
Gynecol Oncol; 1992 Oct; 47(1):76-9. PubMed ID: 1427406
[TBL] [Abstract][Full Text] [Related]
30. Significance of positive peritoneal cytology for recurrence and survival in patients with endometrial cancer.
Ueno Y; Toyoshima M; Shigemi D; Yumori A; Wakabayashi R; Kitagawa M; Konnai K; Onose R; Suzuki S; Kato H
J Obstet Gynaecol Res; 2023 Jan; 49(1):304-313. PubMed ID: 36210139
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic pitfalls of peritoneal washing cytology and the role of cell blocks in their diagnosis.
Selvaggi SM
Diagn Cytopathol; 2003 Jun; 28(6):335-41. PubMed ID: 12768641
[TBL] [Abstract][Full Text] [Related]
32. Primary tumor types and origins in positive abdominopelvic washing cytology, a single institution experience.
Hou Y; Bruehl FK; McHugh KE; Reynolds JP
J Am Soc Cytopathol; 2020; 9(2):89-94. PubMed ID: 31734259
[TBL] [Abstract][Full Text] [Related]
33. Annual report of the Committee on Gynecologic Oncology, the Japan Society of Obstetrics and Gynecology.
Yamagami W; Aoki D
J Obstet Gynaecol Res; 2015 Feb; 41(2):167-77. PubMed ID: 25370711
[TBL] [Abstract][Full Text] [Related]
34. Positive peritoneal cytology is an independent risk-factor in early stage endometrial cancer.
Garg G; Gao F; Wright JD; Hagemann AR; Mutch DG; Powell MA
Gynecol Oncol; 2013 Jan; 128(1):77-82. PubMed ID: 23032094
[TBL] [Abstract][Full Text] [Related]
35. Annual report of the committee on gynecologic oncology, the Japan Society of Obstetrics and Gynecology: Annual patient report for 2019 and annual treatment report for 2014.
Yoshino K; Kurita T; Takahashi F; Nagase S;
J Obstet Gynaecol Res; 2022 Jul; 48(7):1570-1579. PubMed ID: 35633031
[TBL] [Abstract][Full Text] [Related]
36. Peritoneal washing cytology.
Shield P
Cytopathology; 2004 Jun; 15(3):131-41. PubMed ID: 15165269
[TBL] [Abstract][Full Text] [Related]
37. Preoperative cervical cytology in endometrial carcinoma and its clinicopathologic relevance.
Fukuda K; Mori M; Uchiyama M; Iwai K; Iwasaka T; Sugimori H; Yamasaki F
Gynecol Oncol; 1999 Mar; 72(3):273-7. PubMed ID: 10053095
[TBL] [Abstract][Full Text] [Related]
38. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
Silva EG; Gershenson DM; Malpica A; Deavers M
Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
[TBL] [Abstract][Full Text] [Related]
39. Cleaved caspase-3 expression is a potential prognostic factor for endometrial cancer with positive peritoneal cytology.
Ogane N; Yasuda M; Kato H; Kato T; Yano M; Kameda Y; Kamoshida S
Cytopathology; 2018 Jun; 29(3):254-261. PubMed ID: 29626374
[TBL] [Abstract][Full Text] [Related]
40. Conversion of intraperitoneal cytology during laparoscopic surgery of uterine cancer.
von Heesen A; Takacs Z; Gabriel L; Hamza A; Linxweiler M; von Heesen M; Meyberg-Solomayer G; Solomayer EF; Juhasz-Böss I
Arch Gynecol Obstet; 2016 Oct; 294(4):847-54. PubMed ID: 27177538
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
